Isolation and characterisation of toxin A-negative, toxin B-positive Clostridium difficile in Dublin, Ireland

Clinical Microbiology and Infection

Volumn 13, Issue 3, 2007, Pages 298-304

  Drudy, Denise ^a   Harnedy, N ^b   Fanning, S ^a   O'Mahony, R ^a   Kyne, L ^b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Clostridium difficile; Cytotoxicity assay; ELISA; Molecular characterisation; PCR; Toxins

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B;

AGED; AMPLICON; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLOSTRIDIUM DIFFICILE; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; HUMAN; IMMUNOASSAY; IRELAND; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; RIBOTYPING; UNIVERSITY HOSPITAL;

CLOSTRIDIUM DIFFICILE;

EID: 34247260039     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01634.x     Document Type: Article

References (38)

1. Kelly CP, LaMont JT. Clostridium difficile infection. Annu Rev Med 1998; 49: 375-390.
2. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002; 346: 334-339.
3. Kyne L, Farrell RJ, Kelly CP. Clostridium difficile. Gastroenterol Clin North Am 2001; 30: 753-777.
4. Archibald LK, Banerjee SN, Jarvis WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004; 189: 1585-1589.
5. Morris AM, Jobe BA, Stoney M, Sheppard BC, Deveney CW, Deveney KE. Clostridium difficile colitis: An increasingly aggressive iatrogenic disease? Arch Surg 2002; 137: 1096-1100.
6. Dallal RM, Harbrecht BG, Boujoukas AJ et al. Fulminant Clostridium difficile: An underappreciated and increasing cause of death and complications. Ann Surg 2002; 235: 363-372.
7. Pepin J, Valiquette L, Alary ME et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: A changing pattern of disease severity. CMAJ 2004; 171: 466-472.
8. Warny M, Pepin J, Fang A et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366: 1079-1084.
9. Borriello SP, Barclay FE, Reed PJ, Welch AR, Brown JD, Burdon DW. Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C. difficile toxins A and B and latex reactive protein. J Clin Pathol 1987; 40: 573-580.
10. Pothoulakis C. Pathogenesis of Clostridium difficile-associated diarrhoea. Eur J Gastroenterol Hepatol 1996; 8: 1041-1047.
11. Pothoulakis C, Lamont JT. Microbes and microbial toxins: Paradigms for microbial-mucosal interactions. II. The integrated response of the intestine to Clostridium difficile toxins. Am J Physiol Gastrointest Liver Physiol 2001; 280: G178-G183.
12. Savidge TC, Pan WH, Newman P, O'Brien M, Anton PM, Pothoulakis C. Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine. Gastroenterology 2003; 125: 413-420.
13. Cohen SH, Tang YJ, Silva J. Analysis of the pathogenicity locus in Clostridium difficile strains. J Infect Dis 2000; 181: 659-663.
14. Rupnik M, Braun V, Soehn F et al. Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile. FEMS Microbiol Lett 1997; 148: 197-202.
15. Rupnik M, Kato N, Grabnar M, Kato H. New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J Clin Microbiol 2003; 41: 1118-1125.
16. Cohen SH, Tang YJ, Hansen B, Silva J. Isolation of a toxin B-deficient mutant strain of Clostridium difficile in a case of recurrent C. difficile-associated diarrhea. Clin Infect Dis 1998; 26: 410-442.
17. Borriello SP, Wren BW, Hyde S et al. Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun 1992; 60: 4192-4199.
18. Torres JF. Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A. J Med Microbiol 1991; 35: 40-44.
19. Alfa MJ, Kabani A, Lyerly D et al. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000; 38: 2706-2714.
20. Kuijper EJ, de Weerdt J, Kato H et al. Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur J Clin Microbiol Infect Dis 2001; 20: 528-534.
21. Johnson S, Kent SA, O'Leary KJ et al. Fatal pseudomembranous colitis associated with a variant Clostridium difficile strain not detected by toxin A immunoassay. Ann Intern Med 2001; 135: 434-438.
22. al-Barrak A, Embil J, Dyck B et al. An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital. Can Commun Dis Rep 1999; 25: 65-69.
23. Sambol SP, Merrigan MM, Lyerly D, Gerding DN, Johnson S. Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease. Infect Immun 2000; 68: 5480-5487.
24. Johnson S, Sambol SP, Brazier JS et al. International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants. J Clin Microbiol 2003; 41: 1543-1547.
25. Soehn F, Wagenknecht-Wiesner A, Leukel P et al. Genetic rearrangements in the pathogenicity locus of Clostridium difficile strain 8864: implications for transcription, expression and enzymatic activity of toxins A and B. Mol Gen Genet 1998; 258: 222-232.
26. von Eichel-Streiber C, Zec-Pirnat I, Grabnar M, Rupnik M. A nonsense mutation abrogates production of a functional enterotoxin A in Clostridium difficile toxinotype VIII strains of serogroups F and X. FEMS Microbiol Lett 1999; 178: 163-168.
27. Chaves-Olarte E, Low P, Freer E et al. A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins. J Biol Chem 1999; 274: 11046-11052.
28. Kato H, Kato N, Watanabe K et al. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol 1998; 36: 2178-2182.
29. Rupnik M, Avesani V, Janc M, von Eichel-Streiber C, Delmee M. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 1998; 36: 2240-2247.
30. Stubbs SL, Brazier JS, O'Neill GL, Duerden BI. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 1999; 37: 461-463.
31. Rupnik M. How to detect Clostridium difficile variant strains in a routine laboratory. Clin Microbiol Infect 2001; 7: 417-420.
32. Lyerly DM, Neville LM, Evans DT et al. Multicenter evaluation of the Clostridium difficile TOX A/B TEST. J Clin Microbiol 1998; 36: 184-190.
33. Brazier JS, Stubbs SL, Duerden BI. Prevalence of toxin A negative/B positive Clostridium difficile strains. J Hosp Infect 1999; 42: 248-249.
34. Barbut F, Lalande V, Burghoffer B, Thien HV, Grimprel E, Petit JC. Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J Clin Microbiol 2002; 40: 2079-2083.
35. Komatsu M, Kato H, Aihara M et al. High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection. Eur J Clin Microbiol Infect Dis 2003; 22: 525-529.
36. Samra Z, Talmor S, Bahar J. High prevalence of toxin A-negative toxin B-positive Clostridium difficile in hospitalized patients with gastrointestinal disease. Diagn Microbiol Infect Dis 2002; 43: 189-192.
37. Barbut F, Delmee M, Brazier JS et al. A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect 2003; 9: 989-996.
38. van den Berg RJ, Legaria MC, de Breij A, van der Vorm ER, Brazier JS, Kuijper EJ. Introduction of TcdA-negative, Tcd-positive Clostridium difficile in a general hospital in Argentina. Clin Microbiol Infect 2005; 11 (suppl 2): 488.